知镜 Cognispect · 医学文献与研究工作台

Concerted changes in the pediatric single-cell intestinal ecosystem before and after anti-TNF blockade.

Zheng HB, Doran BA, Kimler K, Yu A, Tkachev V, Niederlova V, Cribbin K, Fleming R, Bratrude B, Betz K, Cagnin L, McGuckin C, Keskula P, Albanese A, Sacta M, de Sousa Casal J, van Esch R, Kwong AC, Kummerlowe C, Taliaferro F, Fiaschi N, Kou B, Coetzee S, Jalal S, Yabe Y, Dobosz M, Wipperman MF, Hamon SC, Kalliolias GD, Hooper A, Lim WK, Haxhinasto S, Wei Y, Ford M, Ambartsumyan L, Suskind DL, Lee D, Deutsch GH, Deng X, Collen LV, Mitsialis V, Snapper SB, Wahbeh G, Shalek AK, Ordovas-Montanes J, Kean LS.
eLife · 2026-09-01 · PMID 42678060

文献摘要

Crohn's disease is an inflammatory bowel disease (IBD) commonly treated through anti-TNF blockade. However, most patients still relapse and inevitably progress. Comprehensive single-cell RNA-sequencing (scRNA-seq) atlases have largely sampled patients with established treatment-refractory IBD, limiting our understanding of which cell types, subsets, and states at diagnosis anticipate disease severity and response to treatment. Here, through combining clinical, flow cytometry, histology, and scRNA-seq methods, we profile diagnostic human biopsies from the terminal ileum of treatment-naive pediatric patients with Crohn's disease (pediCD; n = 14), matched repeat biopsies (pediCD-treated; n = 8) and from non-inflamed pediatric controls with functional gastrointestinal disorders (FGIDs; n = 13). To resolve and annotate epithelial, stromal, and immune cell states among the 201,883 baseline single-cell transcriptomes, we develop a principled and unbiased tiered clustering approach, ARBOL. Through flow cytometry and scRNA-seq, we observe that treatment-naive pediCD and FGID have similar broad cell type composition. However, through high-resolution scRNA-seq analysis and microscopy, we identify significant differences in cell subsets and states that arise during pediCD relative to FGID. By closely linking our scRNA-seq analysis with clinical meta-data, we resolve a vector of T cell, innate lymphocyte, myeloid, and epithelial cell states in treatment-naive pediCD (pediCD-TIME) samples, which can distinguish patients along the trajectory of disease severity and anti-TNF response. By using ARBOL with integration, we position repeat on-treatment biopsies from our patients between treatment-naive pediCD and on-treatment adult CD. We identify that anti-TNF treatment pushes the pediatric cellular ecosystem toward an adult, more treatment-refractory state. Our study jointly leverages a treatment-naive cohort, high-resolution principled scRNA-seq data analysis, and clinical outcomes to understand which baseline cell states may predict Crohn's disease trajectory.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。